Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
about
SV2 mediates entry of tetanus neurotoxin into central neuronsThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetamBrivaracetam: a rational drug discovery success storyReview of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizuresNew molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channelsMolecular targets for antiepileptic drug developmentSV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosisThe iTRAPs: Guardians of Synaptic Vesicle Cargo Retrieval During EndocytosisMolecular mechanisms driving homeostatic plasticity of neurotransmitter releaseOpioid receptors: toward separation of analgesic from undesirable effectsA systems level, functional genomics analysis of chronic epilepsySynaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and BeyondBrivaracetam (UCB 34714)Epilepsy caused by an abnormal alternative splicing with dosage effect of the SV2A gene in a chicken modelLevetiracetam reverses synaptic deficits produced by overexpression of SV2AExploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesisDevelopment and Validation of a New Mouse Model to Investigate the Role of SV2A in EpilepsySV2B regulates synaptotagmin 1 by direct interactionPrediction of gene-phenotype associations in humans, mice, and plants using phenologsSynaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmissionModulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.Early development of the gonadotropin-releasing hormone neuronal network in transgenic zebrafishLevetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.The mammalian central nervous synaptic cleft contains a high density of periodically organized complexesGene expression profiling of two distinct neuronal populations in the rodent spinal cord.Loss of the Synaptic Vesicle Protein SV2B results in reduced neurotransmission and altered synaptic vesicle protein expression in the retina.SVOP is a nucleotide binding protein.Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled ratsIntravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies.Puzzling Out Synaptic Vesicle 2 Family Members Functions.Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.Cotrafficking of SV2 and synaptotagmin at the synapse.Levetiracetam as an alternative therapy for Tourette syndrome.Kisspeptins modulate the biology of multiple populations of gonadotropin-releasing hormone neurons during embryogenesis and adulthood in zebrafish (Danio rerio).SV2 acts via presynaptic calcium to regulate neurotransmitter release.Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex.Molecular mechanisms of neurotransmitter release.SV2 regulates neurotransmitter release via multiple mechanisms.Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356× mutation in synapsin I.Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice.
P2860
Q21090499-96EE22B7-AFD1-43E6-ACE1-85B90B42146BQ24561949-10B80971-2A2C-4357-95B9-203D3F3F637EQ24642768-E4D209C2-6819-437D-8003-C31D1244E2A6Q24650880-E80A45FC-1C9C-4E20-9380-C24C7486AFA8Q24654230-73705DA6-3C5B-478D-B90E-A678758B76E2Q24683346-F6D0434E-E06B-4132-98B7-813EAF1721A9Q26269919-6C49EC14-E128-48AF-81F5-CBA83C72608DQ26768190-93F24507-7BFB-43C3-8D45-8CFC7A2C4C44Q26823427-8820F575-D6FD-43F9-B7F7-E948E8959888Q27002925-8165A3F8-7AC8-43B9-A54F-FD9D0BC5E29EQ27335505-C8B6315F-7311-4909-9545-036B18A77DB5Q28068507-8239925E-E71E-4806-8CB1-E9C06BCCED5DQ28281403-4D793BF0-D899-4132-A8A1-CA9EE6C634C3Q28477672-820C3D08-1FA9-4DF1-877D-6FF74116359CQ28478633-0942C53A-FC19-4CE7-B52F-2F9AB23D9C3BQ28543500-1A95346B-1DD4-433B-B934-3DA03A2FEA9DQ28553612-C7C3E2F7-D754-4F31-8CAD-D3F094494669Q28585094-B6FA4710-803C-49A5-B56F-9F228EB6FF5BQ28679989-88AE5CC2-EB02-4ABF-AAD5-84BC8AD9A63AQ29144205-277CB325-D682-49C0-ADCA-C52AB8F1DCFCQ30435547-42B44900-EFC6-44EC-A744-D920F135DDE1Q30543846-FF43D56E-4DFA-47AC-9AC9-EE43C8875C64Q31110554-AF7A9331-8BEC-4A78-934F-91ED00F77431Q33229477-6706D324-68E7-47DC-BC13-06E67844B3FBQ33377039-26EBFF00-A340-4DF0-AE44-D7C376EB65D8Q33432742-1B3AFA52-F51D-4300-9729-3D3537A02D5BQ33434528-EC9412CF-04CF-42FA-B8FE-B1B9199D0518Q33526866-9C830985-6634-4A0F-8282-3FF8019CF78DQ33709815-B9510146-10E1-4C8D-A555-87A2A1D5DA29Q33710870-918F18C5-6E4D-4D78-9C75-567CE3C14572Q33761706-FCB20432-A78E-4C1F-A75A-6A1B4FB14E12Q33835261-F451FD33-EFA0-4DBD-B576-D65DFAB85FD9Q33966358-32DCF89A-D8FE-4EA6-BE0D-E82AA2182787Q34004841-C2C2DEBB-D724-42F2-95D1-844CD72D8FD8Q34034957-92C15620-DF99-48C6-93DA-407B92CDB708Q34132754-08B33916-7AC3-444D-A661-D5D2F1B228BEQ34228641-EF2C90BA-4101-4EB8-A011-82EBE3F3BC48Q34304904-C7B4BDD3-428D-4595-848B-50B7EF7258ACQ34789789-84D8DE99-BF6C-47E1-8CAC-D3093F16A550Q34872576-39E6CDB4-21D0-4776-9757-0FABFD02B44D
P2860
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@ast
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@en
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@nl
type
label
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@ast
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@en
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@nl
prefLabel
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@ast
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@en
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@nl
P2093
P2860
P3181
P356
P1476
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
@en
P2093
J M Gunther
K M Crowder
M R Peterson
R H Scheller
S M Bajjalieh
P2860
P304
P3181
P356
10.1073/PNAS.96.26.15268
P407
P577
1999-12-21T00:00:00Z